Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

Borén, JanChapman, M JohnKrauss, Ronald MPackard, Chris JBentzon, Jacob FBinder, Christoph JDaemen, Mat JDemer, Linda LHegele, Robert ANicholls, Stephen JNordestgaard, Børge GWatts, Gerald FBruckert, EricFazio, SergioFerence, Brian AGraham, IanHorton, Jay DLandmesser, UlfLaufs, UlrichMasana, LuisPasterkamp, GerardRaal, Frederick JRay, Kausik KSchunkert, HeribertTaskinen, Marja-Riittavan de Sluis, BartWiklund, OlovTokgozoglu, LaleCatapano, Alberico LGinsberg, Henry N2021-05-262021-05-262020-06-213205283310.1093/eurheartj/ehz962http://hdl.handle.net/10147/629475enCARDIOVASCULAR DISEASELIPIDSLow-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.Article1522-9645European heart journal